Publications

1. Díaz-Gay M, Dos Santos W, Moody S, Kazachkova M, Abbasi A, Steele CD, et al. (2025). Geographic and age variations in mutational processes in colorectal cancer. Nature. 643(8070):230–40. https://doi.org/10.1038/s41586-025-09025-8 PMID:40267983
2. Senkin S, Moody S, Díaz-Gay M, Abedi-Ardekani B, Cattiaux T, Ferreiro-Iglesias A, et al. (2024). Geographic variation of mutagenic exposures in kidney cancer genomes. Nature. 629(8013):910–8. https://doi.org/10.1038/s41586-024-07368-2 PMID:38693263
3. Pakmanesh H, Anvari O, Forey N, Weiderpass E, Malekpourafshar R, Iranpour M, et al. (2022). TERT promoter mutations as simple and non-invasive urinary biomarkers for the detections of urothelial bladder cancer in a high-risk region. Int J Mol Sci. 23(22):14319. https://doi.org/10.3390/ijms232214319 PMID:36430798
4. Abedi-Ardekani B, Nasrollahzadeh D, Egevad L, Banks RE, Vasudev N, Holcatova I, et al. (2021). Morphological findings in frozen non-neoplastic kidney tissues of patients with kidney cancer from large-scale multicentric studies on renal cancer. Virchows Arch. 478(6):1099–107. https://doi.org/10.1007/s00428-020-02986-3 PMID:33403511
5. Kolijn PM, Smith-Byrne K, Burk V, Viallon V, Lee MA, Papier K, et al. (2025). Multi-cohort high-dimensional proteomics reveals early risk markers for lymphoid cancer subtypes. Nat Commun. 16(1):9517. https://doi.org/10.1038/s41467-025-64534-4 PMID:41152224
6. Ebrahimi E, Sangphukieo A, Park HA, Gaborieau V, Ferreiro-Iglesias A, Diergaarde B, et al.; HEADSpAcE Consortium (2025). Cross-ancestral GWAS identifies 29 variants across head and neck cancer subsites. Nat Commun. 16(1):8787. https://doi.org/10.1038/s41467-025-63842-z PMID:41038832
7. Torrens L, Moody S, de Carvalho AC, Kazachkova M, Abedi-Ardekani B, Cheema S, et al. (2025). The complexity of tobacco smoke-induced mutagenesis in head and neck cancer. Nat Genet. 57(4):884–96. https://doi.org/10.1038/s41588-025-02134-0 PMID:40164736
8. Cortez Cardoso Penha R, Sexton Oates A, Senkin S, Park HA, Atkins J, Holcatova I, et al. (2024). Understanding the biological processes of kidney carcinogenesis: an integrative multi-omics approach. Mol Syst Biol. 20(12):1282–302. https://doi.org/10.1038/s44320-024-00072-3 PMID:39592856
9. Dayton TL, Alcala N, Moonen L, den Hartigh L, Geurts V, Mangiante L, et al. (2023). Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites. Cancer Cell. 41(12):2083–2099.e9. https://doi.org/10.1016/j.ccell.2023.11.007 PMID:38086335
10. Mangiante L, Alcala N, Sexton-Oates A, Di Genova A, Gonzalez-Perez A, Khandekar A, et al. (2023). Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity. Nat Genet. 55(4):607–18. https://doi.org/10.1038/s41588-023-01321-1 PMID:36928603
11. Gabriel AAG, Atkins JR, Penha RCC, Smith-Byrne K, Gaborieau V, Voegele C, et al.; ILCCO consortium (2022). Genetic analysis of lung cancer and the germline impact on somatic mutation burden. J Natl Cancer Inst. 114(8):1159–66. https://doi.org/10.1093/jnci/djac087 PMID:35511172
12. Ferreiro-Iglesias A, McKay JD, Brenner N, Virani S, Lesseur C, Gaborieau V, et al. (2021). Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer. Nat Commun. 12(1):5945. https://doi.org/10.1038/s41467-021-26151-9 PMID:34642315
13. Moody S, Senkin S, Islam SMA, Wang J, Nasrollahzadeh D, Cortez Cardoso Penha R, et al. (2021). Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nat Genet. 53(11):1553–63. https://doi.org/10.1038/s41588-021-00928-6 PMID:34663923
14. Byun J, Han Y, Li Y, Xia J, Long E, Choi J, et al. (2022). Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer. Nat Genet. 54(8):1167–77. https://doi.org/10.1038/s41588-022-01115-x PMID:35915169